Plasma fibronectin is a prognostic biomarker of disability in Parkinson’s disease: a prospective, multicenter cohort study

Shuzhen Zhu(Hubei Provincial Center for Disease Control and Prevention), Qing Wang(Shaoxing People's Hospital), Shujuan Yang(Sichuan University), Wenbiao Xian(Sun Yat-sen University), Fanheng Huang(Zhujiang Hospital), Rongfang Que(Zhujiang Hospital), Ling Ling Chan(Singapore General Hospital), Zihan Chang(Zhujiang Hospital), К. Ray Chaudhuri(NIHR Maudsley Dementia Biomedical Research Unit), Karolina Popławska-Domaszewicz(King's College Hospital NHS Foundation Trust), Chao Deng(University of Wollongong), Eng‐King Tan(SingHealth), Yi‐Heng Zeng(Zhujiang Hospital), Hualin Li(City University of Hong Kong), Zifeng Huang(Guangzhou University of Chinese Medicine), Minzi Li(Guangzhou First People's Hospital), Lucia Batzu(King's College Hospital NHS Foundation Trust), Guixia Li(Hospital of Hebei Province), Lin Shi(Qingdao University), Yanran Liang(Sun Yat-sen University), Jianmin Huang(Hebei Medical University), Shuhan Chen(Southwest Medical University), Mengyan Li(Guangzhou First People's Hospital), Hang Zhou(Shanghai Jiao Tong University), Xiaobo Wei(Zhujiang Hospital), Chengwu Yang(University of Massachusetts Chan Medical School), Ying Pan(Second Affiliated Hospital of Guangzhou Medical University), Zhenchao Xie(Zhujiang Hospital)

npj Parkinson s Disease

January 2, 2025

Cited by 18

|Movement Disorders|2023|351

|Brain|2021|262

|ACS Nano|2022|187

|ACS Nano|2017|183

|Clinical Obesity|2020|183

Related Papers